Parallel Advisors’s Krystal Biotech KRYS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $256K | Buy |
|
|||||
|
2025
Q1 | $312K | Sell |
|
|||||
|
2024
Q4 | $507K | Hold |
|
|||||
|
2024
Q3 | $589K | Hold |
|
|||||
|
2024
Q2 | $594K | Sell |
|
|||||
|
2024
Q1 | $579K | Sell |
|
|||||
|
2023
Q4 | $502K | Sell |
|
|||||
|
2023
Q3 | $484K | Buy |
|
|||||
|
2023
Q2 | $483K | Sell |
|
|||||
|
2023
Q1 | $1.29M | Sell |
|
|||||
|
2022
Q4 | $1.28M | Sell |
|
|||||
|
2022
Q3 | $1.49M | Buy |
|
|||||
|
2022
Q2 | $1.4M | Sell |
|
|||||
|
2022
Q1 | $1.64M | Sell |
|
|||||
|
2021
Q4 | $2.38M | Buy |
|
|||||
|
2021
Q3 | $285K | Hold |
|
|||||
|
2021
Q2 | $371K | Hold |
|
|||||
|
2021
Q1 | $420K | Hold |
|
|||||
|
2020
Q4 | $327K | Hold |
|
|||||
|
2020
Q3 | $235K | Hold |
|
|||||
|
2020
Q2 | $225K | Buy |
|